900 rows · 11 columns

Randomised trial results

A synthetic two-arm trial: 900 subjects, baseline and week-12 scores, adverse events, and a real but modest treatment effect that is easy to overstate if you analyse it badly.

What is in it, and what is wrong with it

The true treatment effect is a 4.1-point improvement on a 0–100 scale. Dropout is informative — subjects doing badly are likelier to leave — so a complete-case analysis will overstate the benefit. There are eleven baseline covariates you could slice by, which is exactly enough for a determined analyst to find a spurious "responder subgroup" at p < 0.05. Try it, then read the multiple-comparisons lesson.

Schema

ColumnTypeDescription
subject_idstringSubject identifier.
armcategorytreatment or placebo.
sitecategoryEnrolling site, 1–6.
ageintegerAge at enrolment.
sexcategoryRecorded sex, F or M.
bmifloatBody mass index at baseline.
prior_therapybooleanWhether the subject had prior therapy.
baseline_scorefloatSymptom score at day 0, 0–100, lower is better.
week12_scorefloatScore at week 12. Empty if the subject dropped out.
dropped_outbooleanWhether the subject left before week 12.
adverse_eventcategorynone, mild, moderate, or severe.

First twelve rows

subject_idarmsiteagesexbmiprior_therapybaseline_score
S1245placebosite-151M24.2true82.3
S1603placebosite-457F32false63.2
S1845placebosite-633M28.1true53.1
S1640treatmentsite-151M27.5false71
S1231placebosite-245F26.1false57.6
S1448treatmentsite-638F20.2true64.2
S1047placebosite-162F30.2false44.3
S1899placebosite-246F33true67.5
S1457placebosite-350F30.2true64.4
S1649placebosite-649F16false57
S1802treatmentsite-357M31.8false72
S1831placebosite-549F23.1false57.9

Showing the first 8 of 11 columns. Open the full table in the Explorer.